Meeting
2020 ASCO Virtual Scientific Program
Genetic polymorphisms associated with clostridium difficile infection in multiple myeloma patients undergoing autologous stem cell transplantation.
Authors
Issam Hamadeh
Levine Cancer Institute, Charlotte, NC
Issam Hamadeh , Zainab Shahid , Manisha Bhutani , Jai Narendra Patel , Nury Steuerwald , Alicia Hamilton , Shebli Atrash , Reed N. Friend , Barry Paul , Peter Michael Voorhees , Saad Zafar Usmani , Jiaxian He
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Plasma Cell Dyscrasia
Track
Hematologic Malignancies
Sub Track
Cell Therapy, Bispecific Antibodies, and Autologous Stem Cell Transplantation for Plasma Cell Disorders
Citation
J Clin Oncol 38: 2020 (suppl; abstr 8522)
DOI
10.1200/JCO.2020.38.15_suppl.8522
Abstract #
8522
Poster Bd #
422
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Phase II trial of umbilical cord blood-derived natural killer cells for multiple myeloma.
First Author: Nina Shah
Poster
2023 ASCO Annual Meeting
Busulfan, melphalan, and carfilzomib (BuMelCar) conditioning for autologous stem cell transplant (ASCT) in multiple myeloma: Phase I/II data.
First Author: Joseph Allan Norton
Poster
2022 ASCO Annual Meeting
Impact of second primary malignancy post-autologous hematopoietic stem cell transplantation on outcomes of multiple myeloma: A CIBMTR analysis.
First Author: Brittany K. Ragon
Poster
2020 ASCO Virtual Scientific Program
Genome Wide Association Study (GWAS) of cognitive impairment after blood or marrow transplantation (BMT) for hematologic malignancy.
First Author: Noha Sharafeldin